Candriam SCA’s Merrimack Pharmaceuticals, Inc. MACK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-25,420
| Closed | -$291K | – | 791 |
|
|
2017
Q3 | $291K | Sell |
25,420
-67,363
| -73% | -$771K | 0.01% | 699 |
|
|
2017
Q2 | $905K | Sell |
92,783
-16,396
| -15% | -$160K | 0.02% | 589 |
|
|
2017
Q1 | $2.65M | Buy |
109,179
+76,896
| +238% | +$1.86M | 0.05% | 386 |
|
|
2016
Q4 | $1.04M | Buy |
32,283
+3,813
| +13% | +$122K | 0.02% | 511 |
|
|
2016
Q3 | $1.42M | Buy |
28,470
+889
| +3% | +$44.4K | 0.03% | 428 |
|
|
2016
Q2 | $1.17M | Hold |
27,581
| – | – | 0.03% | 406 |
|
|
2016
Q1 | $1.81M | Sell |
27,581
-1,703
| -6% | -$112K | 0.05% | 338 |
|
|
2015
Q4 | $1.82M | Hold |
29,284
| – | – | 0.05% | 311 |
|
|
2015
Q3 | $1.96M | Buy |
29,284
+4,499
| +18% | +$301K | 0.05% | 345 |
|
|
2015
Q2 | $2.41M | Buy |
+24,785
| New | +$2.41M | 0.05% | 333 |
|